Pitfalls of Cost-Effectiveness Analysis in Practice: A TRD Case Example in the United States with Esketamine Versus Oral Antidepressants

Autor:	Jennifer Kern Sliwa, Hoa H. Le, John J. Sheehan, Qiaoyi Zhang, Swapna Karkare, Beth Barber
Rok vydání:	2020
Předmět:	medicine.medical_specialty Cost-Benefit Analysis Health Policy MEDLINE Pharmaceutical Science Pharmacy Cost-effectiveness analysis Antidepressive Agents United States Esketamine Family medicine medicine Humans Ketamine Psychology medicine.drug
Zdroj:	Journal of Managed Care & Specialty Pharmacy. 26:568-569
ISSN:	2376-1032 2376-0540
DOI:	10.18553/jmcp.2020.26.4.568
Popis:	DISCLOSURES: The writing of this letter was supported by Janssen Scientific Affairs. The authors are employees of Janssen Scientific Affairs or Janssen Global Services (Johnson & Johnson).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dd91e66fe32bbd0a1c3597d05684ab7 https://doi.org/10.18553/jmcp.2020.26.4.568 Zobrazit plný text záznamu